Trial intelligence / Profile preview

AUDACU: Desloratadine Dosing in Cold Urticaria

NCT00600847Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Nov 2006
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of desloratadine in Cold urticaria (CU), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2006; status: completed.

02

Drugs

desloratadine
03

Conditions

Cold urticaria (CU)

Beyond the preview

Go deeper on NCT00600847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00600847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call